| Original document(21 pages) Authorized document(21 pages) 中文版 |
The present invention relates to a new use of mica in preparing medicine for atrophic gastritis. By means of duplication of rat model of chronic atrophic gastritis, are observed the morphopathological, nuclear proliferation antigen and epidermal growth factor effects of mica and its positive reference medicine sucralfate. The results show that mica can reduce gastric mucosa inflammation cell infiltration and glandulose atrophy, increase the positive expression of glandulose nuclear proliferation antigen and raise the expression level of blood serum epidermal growth factor. That is to say, mica has relatively high rat chronic atrophic gastritis treating effect and certain chronic atrophic gastritis preventing and treating effect. |
Application Number
申请号 |
02110568 |
Application Date
申请日 |
2002.01.17 |
| Title 名称 |
Use of mica in preparing medicine |
Publication Number
公开号 |
1432366 |
Publication Date
公开日 |
2003.07.30 |
| Approval Pub. Date |
|
Granted Pub. Date |
2006.01.18 |
| International Classification 分类号 |
A61K33/06,A61P1/04 |
Applicant(s) Name
申请人 |
Hainan Pulin Pharmaceutical Co., Ltd. |
| Address 地址 |
310009 |
| Inventor(s) Name 发明人 |
Yao Jianmin, Wang Liangjing |
| Attorney & Agent 代理人 |
wang pengju |
| More information 更 多 信 息 |
|
| Related patents information |
|
|
|
|
|
|